MedLife increases loan facility by €50 million

Business Forum
Romanian private healthcare group MedLife has announced an increase in its syndicated credit facility by €50 million, bringing the total to €330 million.

The decision comes after the group achieved revenues of €500 million and has seen turnover growth of over 20% in the last five years.

The syndicate of banks providing the increased loan includes Banca Comercială Română (BCR), Raiffeisen Bank, BRD Groupe Société Générale, Banca Transilvania, and ING Bank N.V. Amsterdam Bucharest Branch. 

BCR acted as coordinator, mandated lead arranger, and facility and guarantee agent.

Mihai Marcu, President and CEO of MedLife Group, said the additional funds will be used primarily to complete ongoing projects and for potential acquisitions, supporting the group's expansion strategy.

Looking ahead, MedLife aims to further expand both domestically and internationally. The group is also focusing on investments in genetics, nutrition, sports, and preventative medicine, which it sees as the future of healthcare. 

MedLife operates in Romania, Hungary and the Republic of Moldova.

RECOMMENDED
Iulius secures €305 million refinancing for Palas Iași
Real estate

Iulius secures €305 million refinancing for Palas Iași

Iulius has secured a €305 million syndicated loan facility to strengthen its development strategy. This represents the first unitary refinancing in Romania for a portfolio of multiple buildings with different functions within a mixed-use project - Palas Iași.

RECOMMENDED FROM THE HOME PAGE
IFC to acquire 10% stake in Romanian pension firm Carpathia
Finance

IFC to acquire 10% stake in Romanian pension firm Carpathia

The International Finance Corporation (IFC), a member of the World Bank Group, has signed an agreement with Vienna Insurance Group (VIG) to acquire approximately 10% of the shares of Carpathia Pensii, a Romanian private pension company.

Industry

Polpharma to launch takeover bid for Biofarm

Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.

READ MORE
Business Forum  |  8 May, 2026 at 7:03 PM
Business Forum  |  8 May, 2026 at 6:00 PM